Grifols | GRFS - Ebit





Ebit تغيير تاريخ
Alaunos Therapeutics USD -1.19M 148K 2025-09
Arca Biopharma USD -34.43M 326K 2025-12
aTyr Pharma USD 24.47M 24.7M 2025-12
Bio Path USD -488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD -2.05M 526K 2025-09
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Immunic USD -22.81M 756K 2024-06
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Nektar Therapeutics USD -19.09M 15.26M 2025-12
TherapeuticsMD USD -1.77M 699K 2023-09